Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AZ, IMS To Build Disparate Data Sets Into Broader Outcomes Consensus

Jan 30 2012

• By Melanie Senior

Related Content

U.K. To Leverage NHS Data As Part Of Broader Stimulus Package, But Details Still Sketchy

Dec 19 2011

AZ’s Brilinta Is First Drug To Clear AMNOG Assessment, While Merck’s Victrelis Limps Forward

Dec 19 2011

PCORI Draft Research Agenda Offers Broad Areas Of Study With Intention Of Getting Specifics From Public Comments

Jan 23 2012

AstraZeneca’s Real-World Outcomes Deal With IMS Aims To Turn Treatment Data Into Business Decisions

Jan 11 2012

Pharma/Payor Deals An Important Step In The Shift To Value-Based R&D

Dec 27 2011

Intermune’s Esbriet Flops In Front Of IQWiG

Dec 19 2011

Related Companies

AstraZeneca PLC

Merck & Co., Inc.

InterMune, Inc.

Additional Topics

Europe United States Deals Reimbursement BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window